Infervision, a Chinese medical imaging artificial intelligence system developer launches its AI-based solution InferRead CT Lung Covid-19. Photo: Handout Infervision, a Chinese medical imaging artificial intelligence system developer launches its AI-based solution InferRead CT Lung Covid-19. Photo: Handout
Infervision, a Chinese medical imaging artificial intelligence system developer launches its AI-based solution InferRead CT Lung Covid-19. Photo: Handout

Chinese medical imaging start-up faces twin hurdles in US market for coronavirus screening amid political row

  • Infervision has repurposed its analytical software for lung cancer analysis since February to help fight the Covid-19 pandemic
  • Beijing-based start-up, backed by private equity funds, is hoping to crack the US market as infection and death toll increase

Topic |   Coronavirus China
Infervision, a Chinese medical imaging artificial intelligence system developer launches its AI-based solution InferRead CT Lung Covid-19. Photo: Handout Infervision, a Chinese medical imaging artificial intelligence system developer launches its AI-based solution InferRead CT Lung Covid-19. Photo: Handout
Infervision, a Chinese medical imaging artificial intelligence system developer launches its AI-based solution InferRead CT Lung Covid-19. Photo: Handout
READ FULL ARTICLE